AFFICHEM announces the presentation of an oral communication at the 35th Annual Meeting of the French Society of Hematology (SFH) in Paris.

AFFICHEM announces the presentation of an oral communication at the 35th Annual Meeting of the French Society of Hematology (SFH) in Paris.

AFFICHEM partner of the European project TARGEAR

AFFICHEM partner of the European project TARGEAR

AFFICHEM integrates the TARGEAR European consortium dedicated to the research against age-related hearing loss.
Science publication

Science publication

Cholesterol metabolites can promote or suppress breast cancer.
Nature Communications publication

Nature Communications publication

The joint research between Affichem and the INSERM UMR1037 team co-led by Dr. Marc & Sandrine Poirot has led to the characterization of the Dendrogenin A as the first steroidal alkaloid identified in humans.
Affichem captures the listening of the European Union

Affichem captures the listening of the European Union

Affichem focuses on the development of a revolutionary drug against deafness through an EU grant of € 2.8 million obtained in September 2012.
NCE - Biomarker - Drug design - Anticancer therapy - Cell differentiation - Receptor - Enzyme - Metabolism - Cancer - Deafness - Deafness - Melanoma - Neurodegenerative disease - Medicinal chemistry - Biotechnology - First in class molecule - New Chemical Entities - Cholesterol - Tamoxifen - Immunotherapy - Exosome - Oncology - Dendritic cell - Theranostic - Diagnosis - Prognosis -